For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Preservative: 0.02% Sodium Azide
Constituents: 50% Glycerol, PBS (without Mg2+ and Ca2+), 150mM Sodium chloride, pH 7.4
Concentration information loading...
Immunogen affinity purified
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||1/500 - 1/1000. Detects a band of approximately 89 kDa (predicted molecular weight: 89 kDa).
||1/50 - 1/100.
Involved in transcriptional regulation. Represses the transcription of a number of genes including gastrin, stromelysin and enolase. Binds to the G-rich box in the enhancer region of these genes.
Belongs to the krueppel C2H2-type zinc-finger protein family.
Contains 4 C2H2-type zinc fingers.
Information by UniProt
- Transcription factor ZBP-89 antibody
- Transcription factor ZBP89 antibody
- ZBP89 antibody
Anti-ZNF148 antibody images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ZNF148 antibody (ab69933)
Immunohistochemical analysis of paraffin embedded human brain tissue using ab69933 at 1/50 dilution. Right panel was treated with immunising peptide.
Western blot - Anti-ZNF148 antibody (ab69933)
All lanes : Anti-ZNF148 antibody (ab69933) at 1/500 dilution
Lane 1 : HepG2 cell extract
Lane 2 : HepG2 cell extract with immunising peptide at 10 µg
Lysates/proteins at 30 µg per lane.
Predicted band size : 89 kDa
Observed band size : 89 kDa
Additional bands at : 95 kDa. We are unsure as to the identity of these extra bands.
References for Anti-ZNF148 antibody (ab69933)
This product has been referenced in:
- Gao XH et al. ZNF148 modulates TOP2A expression and cell proliferation via ceRNA regulatory mechanism in colorectal cancer. Medicine (Baltimore) 96:e5845 (2017).
Read more (PubMed: 28072746) »
- Zhang W et al. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer. World J Gastroenterol 21:8836-47 (2015).
Read more (PubMed: 26269673) »
See all 4 Publications
for this product
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"